Deferred Revenue (Tables)

3 Months Ended

Mar. 31, 2018

Revenue Recognition [Abstract]

Schedule of Deferred Revenue Activity

The following is a summary of the Company’s deferred revenue activity as of March 31, 2018:

(in thousands)	OORT			BED				Other Opioid Treatments			Total
Balance as of December 31, 2017		—			895				1,600		2,495
Recognized as revenue		—			(54		)		—		(54		)
Balance as of March 31, 2018		$	—		$	841			$	1,600	$	2,441

Deferred Revenue, by Arrangement

The remaining $2.2 million was recorded as a long-term liability as of March 31, 2018, as detailed in the following table: 

(in thousands)	OORT			BED			Other Opioid Treatments			Total
Current portion		$	—		$	277		$	—		$	277
Long-term portion		—			564			1,600			2,164
Total		$	—		$	841		$	1,600		$	2,441